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Abstract
Effective and safe COVID-19 vaccines have been developed at a rapid and unprecedented
pace to control the spread of the virus, and prevent hospitalisations and deaths. However,
COVID-19 vaccine uptake is challenged by vaccine hesitancy and anti-vaccination sentiments, a global shortage of vaccine supply, and inequitable vaccine distribution especially
among low- and middle-income countries including the Philippines. In this paper, we
explored vaccination narratives and challenges experienced and observed by Filipinos during the early vaccination period. We interviewed 35 individuals from a subsample of 1,599
survey respondents 18 years and older in the Philippines. The interviews were conducted in
Filipino, Cebuano, and/or English via online platforms such as Zoom or via phone call. All
interviews were recorded, transcribed verbatim, translated, and analysed using inductive
content analysis. To highlight the complex reasons for delaying and/or refusing COVID-19
vaccines, we embedded our findings within the social ecological model. Our analysis
showed that individual perceptions play a major role in the decision to vaccinate. Such perceptions are shaped by exposure to (mis)information amplified by the media, the community, and the health system. Social networks may either positively or negatively impact
vaccination uptake, depending on their views on vaccines. Political issues contribute to vaccine brand hesitancy, resulting in vaccination delays and refusals. Perceptions about the
inefficiency and inflexibility of the system also create additional barriers to the vaccine rollout
in the country, especially among vulnerable and marginalised groups. Recognising and
addressing concerns at all levels are needed to improve COVID-19 vaccination uptake and
reach. Strengthening health literacy is a critical tool to combat misinformation that undermines vaccine confidence. Vaccination systems must also consider the needs of marginalised and vulnerable groups to ensure their access to vaccines. In all these efforts to
improve vaccine uptake, governments will need to engage with communities to ‘co-create’
solutions.
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Challenges to COVID-19 vaccination

Introduction
The coronavirus disease 2019 (COVID-19) pandemic continues to burden health systems and
communities globally, with millions of cases and deaths [1]. Because of the significant and continued impact of COVID-19, vaccines have been developed at a rapid and unprecedented pace
to control the spread of the virus, and prevent hospitalisations and deaths [2]. Many vaccines
have been shown to be safe and effective with high-income countries having vaccinated more
than half of their population [3]. Despite the availability of these vaccines, countries are faced
with various challenges including vaccine hesitancy and anti-vaccination sentiments, limited
global supply, and inefficient vaccine deployment [4, 5]. These issues in vaccine uptake,
together with declining community acceptance of other public health interventions, will mean
a delayed recovery and prolonged pandemic [6].
The World Health Organization (WHO) in 2019 identified vaccine hesitancy or the reluctance to vaccinate as one of the top ten threats to global health despite evidence of the important role of vaccines in improving population health outcomes [7]. Together with weak
primary health care and other health challenges, countries especially low- and middle-income
countries (LMICs) will struggle to meet the demands of the communities within their health
system capacity. With the pandemic, countries are further burdened with many health systems
overwhelmed throughout its course. The Philippines presently faces these challenges: vaccine
hesitancy and increasing anti-vaccination sentiments, a weak primary health care system with
efforts to strengthen it through the recently implemented Universal Health Care Law, and an
overwhelmed health system because of the demands of COVID-19 and other public health
problems [8–13]. These challenges are further compounded by a global shortage of vaccine
supply with inequitable vaccine distributions [14].
Historically, the Philippines was one of the countries with generally high vaccine confidence
rates [15]. Following the dengue vaccine controversy in 2017 however, confidence levels have dramatically dropped and have impacted succeeding vaccination efforts including the COVID-19
vaccination campaign [9, 12, 15–17]. Dengvaxia, the world’s first commercially available dengue
vaccine developed by Sanofi Pasteur, was introduced as part of a national school-based immunization programme despite the lack of empirical data on the risks associated with administration
of the vaccine among those not previously infected with dengue or seronegative children [9, 12,
15–17]. By the time reports were released that the vaccine may cause more severe disease among
seronegatives, the Philippines had already inoculated more than 800,000 Filipino school-age children [9]. This was highly politicised, and damaged trust in vaccines and the health sector [9, 12,
15–17]. As a result, immunisation rates dropped and the country saw outbreaks of previously
controlled vaccine-preventable diseases such as measles and polio [18, 19]. In addition to vaccine
hesitancy, the Philippine health system is not prepared for additional health care demands. As
early as the first phase of the pandemic, critical care capacity was overwhelmed with the influx of
patients in hospitals [10, 11]. As of 16 September 2021, the Philippines ranks third among countries with the highest number of newly confirmed cases per one million population [1, 20]. Globally, 42.9% of the world population have received one dose of a COVID-19 vaccine, with much
lower rates in LMICs like the Philippines [20, 21]. Only 55% of Filipinos have expressed willingness to be vaccinated against COVID-19, and as of 16 September 2021, only 30% of the population have been fully vaccinated[21, 22].
To end this pandemic, it is critical to implement all possible public health interventions and
strategies from face masks, physical distancing, to getting vaccinated [4, 23]. However, there is
a need to recognise that the adoption of all these interventions is influenced by individual risk
perceptions, and these perceptions are shaped by various sources of information and experiences [24]. Additionally, there are interpersonal and structural factors that influence health
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decisions of individuals. Recognising the multiple dimensions in which behaviours and decisions occur, theories and models have been proposed to explain how individuals make decisions on their health based on factors that change over time and context [25, 26]. The social
ecological model provides a useful framework for investigating health behaviours and decisions by recognising that a multiplicity of factors interacts to influence health of individuals
[26]. These include individual factors representing biological or behavioural characteristics,
interpersonal factors representing networks and social capital operating within a defined
boundary, and structural factors that include health systems and are mediated through laws
and policies [26]. Published studies on vaccination that utilised this model reported that vaccine intentions and attitudes operate along multiple dimensions, with a series of events influencing decisions related to vaccination [17, 27, 28]. Improving adherence to interventions and
vaccination rates therefore requires a better understanding of the different reasons behind vaccine mistrust and not just determining their individual beliefs, knowledge, and levels of trust
[17, 27, 28]. A recently published scoping review supports the use of the social ecological
model in understanding attitudes towards COVID-19 vaccination [29]. The review showed
that influencing factors are embedded within the social ecological model and that multilevel
interventions are needed to improve uptake of vaccines [29]. This scoping review of 50 articles
had representation from various countries, but did not include data from the Philippines. We
address this gap by exploring the vaccination narratives and challenges experienced and
observed by Filipinos during the early COVID-19 vaccination period. We used qualitative data
from a mixed-methods study conducted from June to August 2021 that aimed to understand
how people in the Philippines view COVID-19 and what influences their behaviours. With
these findings, we hope to provide insights to possible avenues of future research and directions for improving COVID-19 vaccine uptake and reach.

Material and methods
Design and setting
We conducted an online survey among adults ages 18 and older in the Philippines (n = 1,599)
from June to August 2021. A subsample participated in the semi-structured interviews
(n = 35) with representation from the general population and health workforce from July to
August 2021. Data from the interviews informed the findings of this paper.

Participants and recruitment
We aimed to interview participants from different regions in the Philippines, various age
groups, socio-economic classes, and vaccination status and attitudes. This allowed us to ensure
maximum variation sampling, which aims to capture as many population contexts as possible.
We contacted a total of 115 individuals through the information they provided (i.e., mobile
number, phone number, e-mail). Out of the 115, 35 participants completed the interviews.
The remaining 80 either refused or could not be contacted after a maximum of three attempts.
We classified participants according to their vaccination priority group based on the COVID19 Vaccination Program’s prioritisation framework [30]. Those in the first priority group (A1)
were frontline workers in health facilities; other priority groups (A2 to C) comprised and represented the general population (Table 1).

Data collection
We conducted the interviews in Filipino, Cebuano, and/or English via online platforms such
as Zoom or via phone call. The interview guide included questions about their views on
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Table 1. Vaccine prioritisation framework (2020).
Priority
group

Eligible individuals

A1

Workers in frontline health services

A2

All senior citizens

A3

Persons with comorbidities

A4

Frontline personnel in essential sectors, including uniformed personnel

A5

Indigent population

B1

Teachers, social workers

B2

Other government workers

B3

Other essential workers

B4

Socio-demographic groups at significantly higher risk other than senior citizens and poor
population

B5

Overseas Filipino Workers (OFWs)

B6

Other remaining workforce

C

Rest of the Filipino population not otherwise included in the above groups

https://doi.org/10.1371/journal.pgph.0000165.t001

COVID-19, vaccines, and their risk perceptions and behaviours. We recruited interview participants until saturation was reached (i.e., no new information was being obtained from the
interviews) [31]. The interviews lasted between 60 to 90 minutes with a token amounting to
USD 6 provided to each participant. All participants consented to the interview being
recorded.

Data analysis
The interviews were digitally recorded, transcribed verbatim, and translated from Filipino or
Cebuano to English. The research team are native and/or fluent speakers of the three languages, and checked for linguistic and conceptual equivalence in the translated documents.
We de-identified all participants and assigned pseudonyms. We analysed the data using inductive content analysis focusing on the experiences and views towards vaccination [32]. Our
analysis was guided by principles of grounded theory. Transcripts of the interviews were read
to identify themes and two investigators (AMLA, VCFP) independently coded the interviews
according to emergent themes in Microsoft Excel [33]. We used coding language that was
close to the participants’ terms and phrases to ensure that we were co-constructing accurate
categories reflective of their responses [34]. The codes were reviewed, and areas of disagreement were resolved between the two investigators. Themes from the interviews were further
explored through discussions with the other members of the team. We considered reflexivity
throughout data collection and analysis, acknowledging that our preconceptions and experiences about vaccination as public health practitioners and health professionals may influence
the way we analyse and interpret data. Our use of the grounded theory allowed us to explore
the experiences of our participants and our own shared experiences, and avoided being limited
by how we view COVID-19 vaccination [35]. To highlight the complex reasons for delaying
and/or refusing COVID-19 vaccination, we embedded our findings within the social ecological
model with three broad themes: individual factors (attitudes, beliefs, knowledge, behaviours),
interpersonal factors (relationships and social networks), and structural factors (health systems
and service delivery; media; and policies, regulations, and laws at the local, national, and global
level) [26] (Fig 1). The quotes presented in this paper are either in the original English or
translated from Filipino or Cebuano.
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Fig 1. Social ecological model applied to COVID-19 vaccination. This figure shows the three main tiers of factors influencing vaccination
intention and uptake: individual (beliefs, attitudes, knowledge, health literacy), interpersonal (relationships, networks), and structural (health
systems and service delivery, media, policies). These three dimensions are jointly or individually impacted by misinformation (white circles).
https://doi.org/10.1371/journal.pgph.0000165.g001

Patients and public involvement
The public were not directly involved in the design, recruitment, conduct, reporting, or dissemination plans of this research. Their only involvement was as research participants.

Ethics statement
This study was approved by the University Research Ethics Office of Ateneo de Manila University (Study No. SMPH CORISK 2021). All participants were informed about the aims and
objectives of the study by including the written consent form in the email correspondence.
Prior the interview, the research team thoroughly explained the study to them and provided
them the opportunity to ask questions they may have. Written digital consent was taken from
study participants before the interview.

Results
We interviewed 35 participants with representation from different vaccination priority groups
working in various parts of the country. Our participants also had different educational backgrounds, employment status, and vaccination attitude (Table 2). There was an almost equal
proportion of females and males (females: 19; males: 16) with a median age of 38 years old
(range: 21 to 74 years old) in the overall study population.
Participant views on the barriers to COVID-19 vaccination are presented below, organised
using the three tiers of the social ecological model. Individual barriers include perceptions;
attitudes; and beliefs about the science, about vaccines, about the health system and
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Table 2. Characteristics of interview participants.
Characteristic

Median age (years)

Priority group
A1 (n = 15)

A2 (n = 5)

A3 (n = 4)

A4 (n = 5)

B (n = 4)

C (n = 2)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

37

67

45

29

33

37

Female

9 (60)

3 (60)

2 (50)

2 (40)

3 (75)

0 (0)

Married

6 (40)

4 (80)

1 (25)

1 (20)

2 (50)

1 (50)

Finished university education or higher

15 (100)

5 (100)

4 (100)

3 (75)

3 (75)

2 (100)

Positive towards COVID-19 vaccines

14 (93)

2 (40)

2 (50)

5 (100)

2 (50)

2 (100)

https://doi.org/10.1371/journal.pgph.0000165.t002

government. Interpersonal barriers are the networks and social capital that influence health
beliefs and decisions. Vaccine procurement, supply, and logistics, together with media- and
policy-related issues, comprise the structural barriers. Where there are differences between the
general population and health workers, these are highlighted in the text.

Individual barriers
Vaccine brand hesitancy and brand preferences. Vaccine brand hesitancy or delay in
getting the vaccine due to brand preferences was a common theme among the participants.
The country’s first administered vaccine was Sinovac-CoronaVac, which is manufactured by a
Chinese biopharmaceutical company. This was given to health workers despite lack of published data on effectiveness at the time and initial announcements that these were not recommended for high-risk individuals (Quote I1, Table 3). In addition to concerns about the
effectiveness of the vaccine, participants also read and heard information on how this vaccine
was made. They believed this specific vaccine was using the same virus to ‘immunise’ an individual’s system, which may have unintended effects (Quote I2, Table 3). Other participants
cited that this specific brand was not recognised by other countries, and therefore wanted and
waited for other vaccines. Meanwhile, others refused to receive mRNA vaccines due to beliefs
about its safety and effectiveness.
Negative experiences with the health system as source of vaccine hesitancy and anti-vaccination sentiments. The participants cited negative experiences in the past, whether these
happened recently or decades ago, as causes of their negative attitude towards vaccines. Three
participants who identified themselves as COVID-19 ‘anti-vaxxers’ or those opposed to vaccines, had different sources of anti-vaccination sentiments. These three participants belong to
different priority groups. One belongs to the A1 or frontliner group and is working as a Barangay Health/Emergency Response Team (BHERT) member who responds to COVID-19 related
health care needs in the community. The second is a retired professional (A2 or senior citizen
group) while the third is an environmental protection officer who oversees implementation of
public health standards in the community (B2 or other government workers). These participants experienced an undesired event related to vaccines and/or medical care from four years
to more than three decades prior the pandemic (Quotes I3-I5, Table 3). Except for one antivaxxer, no other health worker reported negative experiences that caused mistrust in the
COVID-19 vaccines and vaccination campaign.
Vaccines are viewed as unsafe and deadly. Perceptions on risk of getting infection with
and dying from the virus varied among the participants. However, for those who were opposed
to the vaccines, their fear of the COVID-19 vaccine and its effects was greater than their fear of
the virus and outcomes (Quote I6, Table 3). This fear and their view of vaccines being unsafe
and deadly resulted to vaccine refusals or delays. According to them, the deaths observed after
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Table 3. Illustrative quotes for individual barriers.
Quote
ID

Theme

Illustrative quote

I1

Vaccine brand hesitancy and brand preferences

I had concerns with Sinovac. I read about the studies
published about vaccines and Sinovac initially did not
publish their results. For me, I did not want Sinovac.
[. . .] There was even a time when the Department of
Health said, “Sinovac is not for health workers”. I still
think some vaccines are better than others (A1, 51–60
years old, male, Laguna).

I2

Vaccine brand hesitancy and brand preferences

I had myself registered, then I did not go, then I
registered, then did not go. Then when I went
through the third registration, they [local government
unit] asked in their website, “Why did you not show
up the last time you were scheduled”? The choices for
refusal were: conflict in schedule, choice of vaccine,
and three other reasons. I chose choice of vaccine.
After that, they scheduled me to another vaccination
site to get my vaccine. When I went, I was still not in
any way sure that it was Pfizer. But I knew it would
not be Sinovac. So I was open to whatever vaccine it
will be, except for Sinovac. So knowing that it was not
Sinovac convinced me to go. Well, regardless if it was
AstraZeneca or other vaccines, I was okay with it as
long as it was not Sinovac. Because I heard that they
used the same virus, they cased it in the vaccine, and
it was like you will have the virus in your body? So
the negativity as well as the news about it. That was
really a major reason that I wouldn’t go for Sinovac
(A3, 41–50 years old, female, National Capital
Region).

I3

Negative experiences with the health system as
source of vaccine hesitancy and anti-vaccination
sentiments

I self-study medicine because I do not want to
depend on doctors. If I did, maybe I died a long time
ago. [. . .] Once upon a time in my life, I was admitted
in the hospital. I was later diagnosed with UTI
[urinary tract infection] but was initially asked for an
ultrasound because they thought I was pregnant.
Another doctor asked me to drink beer for my UTI.
From that [day] on, I just self-studied medicine. With
COVID, I don’t really believe [what I read and hear]
without validation. A former scientist working at
Pfizer insisted that vaccines do not help COVID-19.
Because vaccines are not good for our body. [. . .]
And even the medical practitioners or doctors
themselves cannot help if someone suffers the adverse
reaction of the vaccine (A1, 51–60 years old, female,
Misamis Oriental).

I4

Negative experiences with the health system as
source of vaccine hesitancy and anti-vaccination
sentiments

I was working in a school and was looking after a
child whose mother was busy. The child was very
smart, but was diagnosed with autism. When he had
check-ups, I would accompany him and observe.
Then I researched about autism, and found that it is
caused by vaccines. No wonder there are many
children with autism; it is associated with vaccines
(A2, 61–70 years old, female, Camarines Norte).
(Continued )
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Table 3. (Continued)
Quote
ID

Theme

Illustrative quote

I5

Negative experiences with the health system as
source of vaccine hesitancy and anti-vaccination
sentiments

When my child was in Grade 5, she was injected with
Dengvaxia and had rashes and headaches. I did not
know until my child told me because there were
children dying from Dengvaxia. My child completed
three doses causing her to feel unwell. I did not know
it was Dengvaxia; I thought the form I signed was for
anti-dengue. My husband and I just prayed because
we were afraid. One classmate of hers even died
because of Dengvaxia, although there was no proof
and autopsy was not done. After that experience, I no
longer allow my children to get any of the vaccines. I
am also not vaccinated against COVID-19 (B2, 41–50
years old, female, National Capital Region).

I6

Negative experiences with the health system as
source of vaccine hesitancy and anti-vaccination
sentiments

I am more afraid of vaccines. Once you inject that
into your body, you will not be able to reverse its
effects or take it out of your system. With COVID, if
you are just careful and follow health protocols, and
strengthen your immune system, I do not think you
will immediately get sick. Compared to the vaccines–
we are not sure how safe they are (B2, 41–50 years
old, female, National Capital Region).

I7

Vaccines are viewed as unsafe and deadly

So I told my son, “Why do we need a booster”?
Because you know, if it’s not really 100% [effective],
you need a booster after 6 [months] or 1 year. You
know what, my son answered me, "You know mom,
if you don’t die from the first dose, they give you a
second dose to make sure that you really die. If you
don’t die from the second dose, then they give you a
booster”. It’s funny, it’s funny (A2, 71–80 years old,
female, Misamis Oriental).

I8

Vaccines are viewed as unsafe and deadly

As early as now, we see that after vaccination, people
are dying. Although medical professionals do not
claim that it is caused by the vaccine. But if we really
apply the law of proximate cause. . . Those individuals
who went to the site to get vaccinated are healthy,
even though they have comorbidities they were okay
prior getting the vaccine. Why is it after the
vaccination, a person will just suddenly die? [. . .] But
then, the doctors would just say that it was not caused
by the vaccine. . . that it was because of his
comorbidity. Before vaccination, he was [alive] and
kicking. But after vaccination, this senior citizen in
our place just died. So this is what we are saying. If
the vaccine is really a guarantee to solve this problem,
then it should not cause mortality (A1, 51–60 years
old, female, Misamis Oriental).

I9

Vaccines are viewed as unsafe and deadly

I do not want mRNA vaccines. Once you play around
with RNA, you just don’t know [what happens after].
The technology is not yet mature (A2, 71–80 years
old, male, Laguna).

I10

Vaccines are viewed as unnecessary and
insufficient to prevent disease

The elderly are just at home. In other words, they
[we] do not go out and interact with people. The
vaccine should just be given to the frontliners and
those working in the health care sector (A2, 61–70
years old, female, Camarines Norte).
(Continued )
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Table 3. (Continued)
Quote
ID

Theme

Illustrative quote

I11

Vaccines are viewed as unnecessary and
insufficient to prevent disease

The elderly and those with comorbidities–they need
the vaccine more than I do. In my experience of
getting COVID, I only had mild disease. I know that
my body can survive. But how about them? How will
they survive? (A4, 21–30 years old, female, National
Capital Region).

I12

Vaccines are viewed as unnecessary and
insufficient to prevent disease

Just because you are vaccinated, it does not mean you
are safe from COVID-19. So why should you get the
vaccine if you are still not safe in the end? My
question is, what are the vaccines for then? (B2, 41–50
years old, female, National Capital Region).

I13

Skepticism towards vaccine incentives

If the vaccine is really that good, then people should
be fighting each other to get it. But how come the
government has to give you an incentive to get the
vaccine? [. . .] If it’s really that good, why the
incentive? If it’s really that good. That’s why it
bothers me. [. . .] If it is for your protection, if it is for
your health, we do not need that [incentive] (A2, 71–
80 years old, female, Misamis Oriental).

I14

Use of vaccines not fully approved by the Food
Drug and Administration

It [the vaccine] needs to under a thorough process or
take many years to have enough clinical studies that
can validate the results or so we can see the adverse
reactions in the human body. I don’t think it’s [the
development process] this easy that in just a matter of
months, we can already use it, right? I don’t think it’s
this easy for them to say that the vaccine is effective to
combat the virus (A1, 51–60 years old, female,
Misamis Oriental).

I15

Use of vaccines not fully approved by the Food
Drug and Administration

I was thinking, maybe this is just an experiment or
study. As in the dengue vaccine, they were just
studying it and injected it among children, and then
found it wasn’t safe. I am thinking the same for
COVID-19 vaccines (B2, 41–50 years old, female,
National Capital Region).

I16

Low health literacy and lack of critical skills to
evaluate health information

I noticed educating people is lacking. For example,
the father of our house help does not want to get the
vaccine because of Dengvaxia. The people we know
who belong to lower income groups always say,
Dengvaxia. It is frustrating because people are not
well-informed about vaccines (A4, 31–40 years old,
male, Rizal).

I17

Low health literacy and lack of critical skills to
evaluate health information

What people know is superficial and information is
not thoroughly discussed in social media or even in
informercials of local governments. So what happens
sometimes is, they do get side effects like fever, chills
during the first vaccination. Then they do not return
for the second, which is a wasted opportunity (A1,
51–60 years old, female, Rizal).

I18

Low health literacy and lack of critical skills to
evaluate health information

They say the vaccines change your DNA. I don’t
know. Actually, I don’t know what to believe in. If
I’m being honest, I don’t know what to believe in (A2,
61–70 years old, female, Camarines Norte).

I19

Religious beliefs do not support vaccines

God created natural antibodies, but these will be
replaced by man-made vaccines. Nothing can replace
what God has created, which may be the reason for
the side effects and deaths (A1, 51–60 years old,
female, Misamis Oriental).

https://doi.org/10.1371/journal.pgph.0000165.t003
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administration of the vaccine are caused by the vaccine; however, medical doctors and hospitals report the death as being caused by underlying conditions such as comorbidities (Quotes
I7-I8, Table 3). Some participants also believed the circulating theory that the life span of
those who are vaccinated is shortened and they only have two to three years to live: “you are
healthy but because of the vaccine, you suddenly die”. In addition to the belief that vaccines
cause death or shorten an individual’s life span, participants also had doubts about the
COVID-19 vaccines particularly the mRNA vaccines that use a relatively new technology
(Quote I9, Table 3). These concerns about the safety profile of vaccines either caused delays in
vaccine acceptance and uptake or refusals. The reverse was reported among most of the health
workers and other participants who viewed vaccines positively. They believed that the vaccine
protects them from severe illness, hospitalisation, and death, and that vaccines only have minimal risk.
Vaccines are viewed as unnecessary and insufficient to prevent disease. Vaccines were
viewed as unnecessary by some participants, especially those in older age groups who are not
allowed to go out (Quote I10, Table 3). Those in lower priority groups felt that others needed
the vaccine more than them. Younger participants shared that they were COVID-19 survivors
even without the vaccine; but those at high risk especially the elderly and persons with comorbidities will need the vaccine to protect them (Quote I11, Table 3). The participants also
viewed vaccines as insufficient–they expected that getting vaccinated means no longer needing
other public health interventions but were disappointed to learn that vaccines are only one
part of the solution. Participants therefore questioned the need for the vaccines given the information they have read and/or watched about still being at risk of getting infected despite being
vaccinated (Quote I12, Table 3). The lack of clarity in the role of the vaccines has negatively
influenced people’s decisions on getting the vaccine.
Skepticism towards vaccine incentives. Vaccine incentives in the country, such as promotions and offers for those vaccinated, created skepticism among some of the participants.
These incentives ‘bothered’ participants and raised questions about the role of vaccines and
the intentions of the government. As a result, these incentives ‘disincentivised’ participants
from getting the vaccine as participants felt being forced to take it (Quote I13, Table 3).
Use of vaccines not fully approved by the Food and Drug Administration (FDA). Participants viewed decisions to vaccinate individuals as ‘rash’ and expressed concerns about vaccines not yet being fully approved by the Food and Drug Administration (FDA). Some also
shared concerns about the rapid development of vaccines compared to other vaccines that
took decades to develop (Quote I14, Table 3). Participants felt that they were being experimented on using an unproven vaccine, relating this with the dengue vaccine controversy
(Quote I15, Table 3). This caused delay or refusal in getting the vaccines when it was offered
to them.
Low health literacy and lack of critical skills to evaluate health information. Health literacy or how people acquire, evaluate, and apply health information to inform their decisions,
including getting the vaccine, is an important but underestimated tool to combat misinformation. Participants shared that Filipinos seemed to know a lot about vaccines, but only superficially. They shared that those among low-resource communities and older population groups
were especially vulnerable to misinformation (Quote I16, Table 3). This lack of awareness and
critical skills to evaluate information, together with the rapid spread of misinformation, influences people’s decisions to get their first dose, to return to their second and get fully vaccinated
(Quote I17, Table 3). There were also several participants who shared that they were confused
with the contradictory information they were reading and hearing (Quotes I18, Table 3).
Religious beliefs do not support vaccines. ‘Antichrist’–this was how one participant
described the vaccines against COVID-19. Another participant shared concerns about the
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vaccines and how they would replace antibodies created by God (Quote I19, Table 3). She
mentioned that these vaccines have active chemicals that are causing unintended side effects
and deaths.

Interpersonal barriers
Family influence and opposition to vaccines. Participants recognised the influence of
their family on their health decisions including getting vaccinated. One participant who was
opposed to COVID-19 vaccines shared that everyone in their family was unvaccinated because
they believed her (A1, 51–60 years old, female, Misamis Oriental). Similarly, a mother who
had a negative experience related to the dengue vaccine that was administered to her child,
refused to have herself and her family vaccinated against COVID-19 (B2, 41–50 years old,
female, National Capital Region).
Misinformation spread by networks. Rumours and misinformation about COVID-19
vaccines are easily spread by networks, whether by word of mouth or through social media. A
participant said her “eyes have been opened only now because of YouTube” (A2, 61–70 years
old, female, Camarines Norte). Participants believed that this affected vaccine uptake, especially among individuals who do not have the opportunity to receive accurate information
from official sources including the Department of Health (Quote IC1, Table 4).
Perceived conflicts of interest of health professionals. Participants viewed key figures in
the response to the pandemic as having conflicts of interests. This perception of having ‘hidden
agenda’ created mistrust in the information provided health professionals, health organisations, and other figures and institutions. These conflicts of interest, whether financial or nonfinancial, subject evidence and data to bias especially if there are undesired adverse effects to
the treatment or vaccine (Quote IC2, Table 4).

Structural barriers: Health systems and service delivery
Inadequate supply of vaccines. Observations of participants regarding supply of vaccines
varied according to location and membership to the vaccine priority groups. Participants,
especially those from cities and provinces outside of metropolitan areas, reported that the supply of vaccines was insufficient to meet the demands and needs of the communities (Quote
S-HS1, Table 5). However, even within highly urbanised areas, participants shared that there
were those who did not get their second doses on time because no vaccines arrived (Quote
Table 4. Illustrative quotes for interpersonal and community barriers.
Quote
ID

Theme

Illustrative quote

IC1

Misinformation spread by
networks

People in the remote areas, especially the middle-aged and senior
citizens, are apprehensive because they heard from other friends
that vaccines may cause damage to their health. [. . .] They said that
when you are vaccinated you are given only two years to live and
that vaccines contain metals [. . .] so a new generation will come out
(A2, 61–70 years old, female, Bukidnon).

IC2

Perceived conflicts of interest of
health professionals

In some way, [name of health professional redacted] is funded by
some drug companies. Once you are involved in these drug firms,
being objective becomes difficult. It is important to be objective, or
else you will bias your findings. Although not directly forced [by the
drug company], but you have information that you know of but
choose to withhold. You will just forget about it, especially if there
are unwanted adverse effects [to the treatment or vaccine] (A2, 71–
80 years old, male, Laguna).

https://doi.org/10.1371/journal.pgph.0000165.t004
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Table 5. Illustrative quotes for structural barriers relating to health systems and service delivery.
Quote
ID

Theme

Illustrative quote

S-HS1

Inadequate supply of vaccines

My [senior citizen, A2] parents in Abra were not able
to get their vaccine yet because of inadequate supply of
vaccines. I think the vaccination rollout is not yet fully
implemented there (A4, 31–40 years old, male,
National Capital Region with parents in Abra,
Benguet).

S-HS2

Inadequate supply of vaccines

Others are not yet fully vaccinated because they could
not get their second dose yet (A4, 31–40 years old,
male, National Capital Region with parents in Abra,
Benguet).

S-HS3

Inadequate supply of vaccines

Many individuals are not yet vaccinated even in [the
first three priority groups] A1 to A3, especially for A2
[senior citizens] and A3 [persons with comorbidities]
because we do not have enough supply of vaccines.
This is one of the bottlenecks–inadequate supply of
vaccines. [. . .] My brother is classified as A3 but he
could not get it because there were no more vaccines
(A1, 21–30 years old, male, Albay)

S-HS4

Perceived inefficiencies of the vaccination
system

This [issue] was when the cases were increasing. We
knew the vaccines were going to be needed but the
government was late in procuring vaccines. Now the
frustration is with the rollout. It is slow. I think we’re
now at 9%, 10% population [that is vaccinated]. It’s
going to be a long way, long way to 70% [to reach herd
immunity] (A1, 51–60 years old, male, Laguna).

S-HS5

Perceived inefficiencies of the vaccination
system

I have a cousin who registered three weeks ago because
he is part of the A4 category. Until now, he still did not
get a schedule [from the local government]. So what I
did, I registered him here at the [health institute]. This
week, just this Thursday, he already has a schedule. I
just registered him last week (A1, 41–50 years old,
male, Laguna).

S-HS6

Perceived inefficiencies of the vaccination
system

“Nadidismaya” [or disappointed] because on the day of
vaccination, there is a two-hour seminar about COVID
and vaccines [. . .] There were people leaving the
vaccination site because they found the two-hour
seminar long, and they were afraid of crowding in one
area (A2, 61–70 years old, male, Nueva Vizcaya).

S-HS7

Perceived inefficiencies of the vaccination
system

I believe there’s this glitch in the registration system of
the city. There’s a bug in the system that significantly
slows down the vaccine rollout (B1, 21–30 years old,
male, National Capital Region).

S-HS8

Perceived inefficiencies of the vaccination
system

The system is not centralised. For example, you were
already vaccinated in one site. But you are also in the
list of another site. I think there should be a feedback
mechanism, “I am vaccinated already, you may remove
me from the list”. So that others waiting can get the slot
(A4, 31–40 years old, male, Rizal).

S-HS9

View that the vaccination system is inflexible
and excludes vulnerable and marginalised
populations

I got my vaccine ahead of my parents. Because I would
always wait for posts from the local government on
Facebook. At the time they announced that
registration was open, I registered myself immediately.
But my parents, they are not inclined to technology so
they would just wait for guidance (C, 21–30 years old,
male, Cebu).
(Continued )
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Table 5. (Continued)
Quote
ID

Theme

Illustrative quote

S-HS10

View that the vaccination system is inflexible
and excludes vulnerable and marginalised
populations

The process takes very long. First, there are so many
steps needed during vaccination. They take the
[person’s] information like name–they will write your
name. Next step, this is repeated, they ask for your
name again. Then they will ask, “do you have
allergies”? There are so many steps that could have
been placed in one station [at the vaccination site].
And another thing, the lines. Everyone who will be
vaccinated is seated. Once someone is done, everyone
stands up and transfers to the next chair. If you are old,
can you imagine standing up, sitting down, standing
up, sitting down? It is painful on the knees. They
should just call everyone in a row, or they should just
call people at a time, with everyone else staying in their
seats. They have so many steps just asking for the
name, these steps take so much time. One and a half
hours. For seniors, this is difficult especially because
everyone lines up [and there is no special lane for
seniors] (A2, 71–80 years old, male, Laguna).

S-HS11

View that the vaccination system is inflexible
and excludes vulnerable and marginalised
populations

My grandmother [A2 priority] is not yet vaccinated.
She shared with me that you need to line up at the
basketball court. My grandmother has difficulties
walking so she cannot go there to line up. She also has
difficulty breathing and there are times she needs
oxygen when going out. So we [family] have this fear
that if we bring her there, instead of it [getting the
vaccine] being a good thing, she might get infected.
One other reason is transportation so her concern is if
the vaccination schedule is announced, “How will I go
there?”. The local government does not have home
vaccination or services that bring the vaccines to
individuals’ homes. But she wants to get the vaccine
(A4, 21–30 years old, female, Cavite)

S-HS12

Logistical challenges

I think logistics is also delaying the vaccination
campaign. For example, Pfizer has special
requirements for storage (A1, 51–60 years old, male,
Laguna).

S-HS13

Logistical challenges

Why do I prefer Moderna? Although Pfizer is more
effective, but its handling is difficult. It requires cold
storage. [. . .] For this reason, my number one
preferred brand is Moderna (A4, 31–40 years old,
male, Rizal).

S-HS14

Health professionals seen as amplifiers of
misinformation

In addition to Ivermectin, vaccines are another debate
within the medical community. I even have a classmate
[in medical school] who is an anti-vaxxer. I said, “Let’s
wait” [for the evidence]. Because others were already
fighting (A1, 51–60 years old, male, Laguna).

S-HS15

Health professionals seen as amplifiers of
misinformation

There are actually doctors who are anti-vaxxers. There
is this specific doctor who had a talk with a public
radio station. Previously, she would not give vaccines,
according to my classmates [in medical school]
working with her because she is doing private practice.
She had a pregnant patient who was referred to her.
She would convince the mother not to have the child
vaccinated (A1, 21–30 years old, male, Iloilo).
(Continued )
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Table 5. (Continued)
Quote
ID

Theme

Illustrative quote

S-HS16

Pandemic response deemed as ineffective affects They’re [institutions] not doing their job they’re
trust in health institutions
supposed to do. That’s not a political statement, that is
the comment of the people on the ground. Us, we in
the masses. . . They are just giving us lies and inciting
fear, and misleading [us] (A3, 51–60 years old, male,
Nueva Vizcaya).

S-HS17

Pandemic response deemed as ineffective affects The Department of Health has daily updates, right? It’s
trust in health institutions
unfortunate that a good number of reacts [on
Facebook] are ‘haha’ reacts. Well, I would understand
that because it’s been more than a year and we are still
at 5,000 to 6,000 cases per day. I would understand the
angry reacts. They would say why is the system not
better, or why are we not getting vaccines right away?
It indicates that people are willing to do their part in
stemming the spread of the virus. But with ‘haha’
reacts, what’s funny? What’s posted there are the
number of people who died that day. These people,
come on [in disbelief] (B1, 21–30 years old, male,
National Capital Region).

S-HS18

Pandemic response deemed as ineffective affects Before, people were worried because of the news
trust in health institutions
circulating in social media about the side effects [of the
vaccine]. It’s a good thing I’m in the health sector so I
know that vaccines are needed. But if I were not a
health worker, I would not get vaccinated because I
might suddenly die. Or maybe the government is just
not telling the truth (A1, 41–50 years old, female,
Rizal).

https://doi.org/10.1371/journal.pgph.0000165.t005

S-HS2, Table 5). Health workers found that vaccines for them were easily accessible, however
those in other groups had to wait longer before getting the vaccine (Quote S-HS3, Table 5).
Perceived inefficiencies of the vaccination system. Participants highlighted issues with
the system including the slow rollout of vaccines, long waiting time, inefficient registration systems, and lack of a centralised system. Participants mentioned getting frustrated with the
speed at which vaccines are being distributed and administered in the country (Quote S-HS4,
Table 5). Participants also mentioned issues with the waiting process to get a slot after registration and the waiting time at the day of the vaccination, with some being asked to stay at vaccination sites for two hours to watch a seminar on COVID-19 and vaccines (Quotes S-HS5-6,
Table 5). There was perceived risk of exposure, which could be lessened if the process was
faster and more efficient. There were also glitches in the online registration systems used by
local governments that caused additional delays in getting people vaccinated (Quote S-HS7,
Table 5). Local governments are responsible for the distribution and administration of vaccines among their constituents, and individuals may register with various local governments
depending on their place of residence or work. This lack of a centralised system makes it difficult to track who have already been vaccinated and where they have been vaccinated such that
those who are still waiting for a slot are unable to secure one (Quote S-HS8, Table 5).
View that the vaccination system is inflexible and excludes vulnerable and marginalised
populations. The current vaccination system of some local governments is viewed as inflexible that excludes vulnerable and marginalised populations. There are individuals who lack
access to technology and digital platforms. Especially in rural areas and among the elderly,
their exclusion due to access issues is further compounded by their low digital health literacy.
These individuals are then unable to register online and get the vaccine (Quote S-HS9,

PLOS Global Public Health | https://doi.org/10.1371/journal.pgph.0000165 January 13, 2022

14 / 23

PLOS GLOBAL PUBLIC HEALTH

Challenges to COVID-19 vaccination

Table 5). While registration is online, even those in older age groups who are part of highly
prioritised groups because of their susceptibility to the virus are required to go to the vaccination centre (Quote S-HS10, Table 5). Similarly, those belonging to marginalised groups and
communities also encounter considerable challenges to getting the vaccine (Quote S-HS11,
Table 5).
Logistical challenges. A participant recognised that there are also logistical constraints in
the distribution of vaccines, in addition to problems with supply. The COVID-19 vaccines
have different temperature requirements with some requiring special distribution systems
(S-HS12, Table 5). These logistical challenges influence the distribution of vaccine brands to
areas that have the capability to store them and affect decisions to delay getting the vaccine
especially among those who prefer other brands (S-HS13, Table 5).
Health professionals seen as amplifiers of misinformation. Misinformation on vaccines
and treatment were not only observed within families and social networks, but also within the
medical community reported by participants who are health professionals themselves. There
have been debates about Ivermectin as treatment for COVID-19, as well as vaccines, which
have created factions within the group (S-HS14, Table 5). Some of these health professionals
who are anti-vaxxers or opposed to vaccines publicly share their views in media and in their
practice (S-HS15, Table 5). Because of the stature and credibility of health professionals, their
views, whether backed by science or not, get amplified in the media and communities.
Pandemic response deemed as ineffective affects trust in health institutions. The
response and messaging of health organisations, together with other key figures and institutions in the country, were viewed by participants as ineffective (S-HS16, Table 5). As a result,
there is declining trust in these organisations with participants doubting information provided, such that Filipinos no longer take the pandemic seriously (S-HS17, S-HS18, Table 5).
In turn, participants turn to other sources of information that they think are more credible
and trustworthy.

Structural barriers: Media and policies
Traditional and digital media accelerating the infodemic. Information on the virus and
vaccines are easily and effectively amplified by the media. With the infodemic (portmanteau of
information and epidemic) or the exponential production of information whether scientifically accurate or not, traditional media and digital media become drivers of (mis)information
or fear towards vaccines (Quotes S-MP1-S-MP2, Table 6). Information that participants were
receiving from these sources influenced their health beliefs and vaccine decisions (Quote
S-MP3, Table 6).
Perceived poor policy implementation and lack of evidence-based policies contributing
to loss of confidence in vaccines and health institutions. The government developed the
Philippine “National Deployment and Vaccination Plan for COVID-19 Vaccines” that identifies population groups to be prioritised ensure vaccine equity accounting for different risks
and needs [36]. This plan also stated that only vaccines granted with emergency use authorisation (EUA) or certificate of product registration (CPR) by the Philippine FDA will be purchased by the government. However, this was reported by participants to be poorly
implemented with others using connections also known as ‘palakasan’ system to get the vaccine ahead of those in the priority list (Quote S-MP4, Table 6). Even within the government,
the Presidential Security Group were given vaccines even without EUA and/or CPR registration from the FDA (Quote S-MP5, Table 6). In addition, the government purchased vaccines
that did not publish their results, and reportedly had lower efficacy rates but more expensive
(Quote S-MP6, Table 6). As a result, participants felt that the government was ‘settling for
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Table 6. Illustrative quotes for structural barriers relating to the media and policies.
Quote
ID

Theme

Illustrative quote

S-MP1

Traditional and digital media accelerating the infodemic

When Sinovac arrived, there were people who refused.
People were afraid of what the media was reporting about
the vaccine. For example, my secretary refused to get
vaccinated. [. . .] Because there was a lot of news about it. I
don’t know if fake news, but there were fears because it’s a
new vaccine, it’s not been tested (A1, 51–60 years old, male,
Laguna).

S-MP2

Traditional and digital media accelerating the infodemic

I got Pfizer from our government, and it was not easy at the
start because of the negative stories that I would hear. The
hearsays from social media [. . .] like Facebook and Twitter.
Because people were reacting already then when the rollout
of vaccinations started. There were stories about people
who had negative body reactions to the first dose, hearsays
from people who would say that the vaccine would shorten
your life span to five years? There were stories like that. It
got me thinking and it got me asking. When people in our
community would ask me if I got vaccinated, I would say
“No, I am afraid” (A3, 41–50 years old, female, National
Capital Region).

S-MP3

Traditional and digital media accelerating the infodemic

Have you read about the New World Order? I read that this
is a ‘plandemic’ instead of pandemic. In other words, this
virus was made in the laboratory in Wuhan, China with the
purpose of depopulating the world. [. . .] I now believe that
we are in the End Times as mentioned in the Bible. It was
only now that my eyes have been opened because of
YouTube (A2, 61–70 years old, female, Camarines Norte).

S-MP4

Perceived poor policy implementation and lack of
evidence-based policies contributing to loss of confidence
in vaccines and health institutions

We cannot avoid it–that those who have connections get
the vaccine first. And then they [government] promised us
that we frontliners and our family members [extended
priority list] will be prioritised for the vaccines. But this is
not true. I was not prioritised and this was the same
experience for my co-workers (A1, 31–40 years old, female,
Pampanga).

S-MP5

Perceived poor policy implementation and lack of
evidence-based policies contributing to loss of confidence
in vaccines and health institutions

The FDA approved Sinopharm [for compassionate use]
even if there were no published trials yet. The vaccination
of the Presidential Security Group was illegal. Why were
they vaccinated illegally? There are many issues with the
government, which make people question the vaccines. So
there were many people who hesitated getting the vaccine,
and they lost confidence in the available vaccines. We,
health workers, had difficulties persuading or convincing
people to get vaccinated (A1, 21–30 years old, male, Albay).

S-MP6

Perceived poor policy implementation and lack of
evidence-based policies contributing to loss of confidence
in vaccines and health institutions

As I have mentioned before, I tend to decide based on what
I know and what I have read. Most of the vaccines that the
government ordered are Sinovac, which did not undergo
phase 3 and peer review. This is the reason why I don’t
believe in our government. Also, Sinovac is more expensive
but has a lower efficacy rate compared to other vaccines
which are cheaper but has higher efficacy rate like
AstraZeneca. Now ask yourself why would your
government prefer a vaccine that is more expensive but
with lower efficacy for its constituents if our government
applied for loans in international banks? (A4, 21–30 years
old, male, National Capital Region)

S-MP7

National and local political issues

My least preferred vaccine brand is Sinovac because of its
country of origin. I do not believe in China. Directly, you
can put that on record. Because of their products and
medicines, and also what they’re doing to us with the West
Philippine Sea. Those things are also now being considered
by people. For me, at least for me. I’m speaking for myself. I
don’t like what they’re doing to us as a country. You can
place that on record (A3, 51–60 years old, male, Nueva
Vizcaya).

(Continued )
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Table 6. (Continued)
Quote
ID

Theme

Illustrative quote

S-MP8

National and local political issues

I watched a video about a scientist in China who is hiding
in Hong Kong. This scientist was revealing the truth about
COVID and how it was created. I think this was created by
China to take over countries especially with what happened
with the West Philippine Sea. They want to make the
Philippines a part of their country. [. . .] With vaccines, I
think other countries are angry at China because that’s
where the virus came from. So these countries developed
their own vaccines as a defense (B2, 41–50 years old,
female, National Capital Region).

S-MP9

National and local political issues

I decided to get Sinovac—I am at risk of getting infected
with the virus because I am frequently exposed to people. I
also don’t think I have the chance to get Pfizer because it is
being shipped to Davao [city where the President and his
family resides]. I would be lucky to get Pfizer, but I do not
have connections with the government (A1, 31–40 years
old, female, Pampanga).

https://doi.org/10.1371/journal.pgph.0000165.t006

less’ and that Filipinos deserved better (A4, 21–30 years old, female, National Capital Region).
These issues contributed to declining confidence in vaccines and health institutions, with Filipinos questioning the safety of such vaccines and the implementation of these prioritisation
frameworks.
National and local political issues. Past and current political issues contributed to refusals to specific vaccine brands. Together with reports of how the virus emerged from Wuhan,
China, these triggered skepticism towards vaccines manufactured in their country. Participants mentioned the dispute of the Philippines and China regarding contested territory at the
West Philippine Sea (South China Sea) as a reason for not preferring and/or refusing vaccines
from their country, even when donations of Sinovac from China were the first vaccines to be
available (Quote S-MP7, Table 6). This dispute also influenced how participants thought
about the origins of the virus and why other countries developed their own vaccines (Quote
S-MP8, Table 6). Locally, participants viewed politics to have influence on which cities or
provinces receive preferred vaccine brands. They mentioned that these ‘favored hospitals and
provinces’ were prioritised, which was perceived as unfair and causing further delays in the
vaccination rollout (Quote S-MP9, Table 6).

Discussion
One of the most effective public health strategies, vaccination, has been the focus of false and
inaccurate information with rapidly declining rates of acceptance. [37]. In the Philippines, vaccine confidence plummeted after the Dengue vaccine controversy [9, 12, 15–17]. While antivaccination views and vaccine hesitancy are not yet the main barrier to vaccination in the Philippines which still struggles with vaccine access and distribution, lessons from other countries
indicate that these equally and urgently need to be addressed in addition to other challenges
[38]. Our study supports the findings of other published research that report a host of individual, interpersonal, and structural barriers that work individually or collectively against vaccination uptake and reach [29]. Therefore, there is a need for a holistic approach to promote
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COVID-19 vaccination that not only addresses barriers at the individual level, but also at the
interpersonal and structural levels [38, 39].
Individual perceptions, beliefs, and experiences play a major role on the decision to vaccinate. These are shaped by exposure to (mis)information spread by networks, by key health figures and institutions, and through the media [40–43]. Misinformation regarding vaccines
have been present since vaccines were first developed [44–46], but the advent of social media
made its propagation much easier [43, 45, 47]. Unique to the Philippine context is vaccine
brand hesitancy, specifically towards Chinese manufactured vaccines and mRNA vaccines.
This is caused in part by lack of transparency and scientific information, and spread through
networks and the media. Further aggravating the issue is how some people attempt to correct
misconceptions in a way that alienates people instead of addressing misinformation. People
involved in vaccine promotion activities, especially primary care providers, may need to be
trained on how to engage with vocal vaccine deniers and promote vaccination. The World
Health Organization document outlining how to respond to vaccine misinformation would be
an important resource in such an endeavour [48]. Celebrities and social media influencers
may also play a role in promoting vaccination [41], but it is essential that they disclose conflicts
of interest to develop trust with their audience. The media also needs to be trained on how to
present news regarding adverse effects following immunsation, and regarding COVID-19 in
general, so as not to create unnecessary panic and dissuade people from getting vaccinated. A
study reported that there may be a need to use first-person, people-centred narratives to prevent ‘psychic numbing’ and give faces to numbers [49]. In all these, it is vital to engage with
the public, especially those who are vaccine hesitant, in order to promote vaccination using
language that is inclusive and applicable to their context [48].
The health system and one’s interactions with it also contribute to one’s decision to get vaccinated. As in this study, trust in the health system has been found to be a major factor in getting COVID-19 vaccine [41, 50]. The Philippine government has instituted several health
system confidence-building policies. The recent COVID-19 Vaccination Program Act stipulates the provision of free COVID-19 vaccines to all Filipinos and the establishment of an
indemnification fund for people who could possibly develop adverse effects following immunisation [51]. Perceptions of ‘palakasan’ (i.e., use of political connections), stemming from
instances during the course of the pandemic where powerful individuals seem to be above the
law [52], contribute to vaccine hesitancy and poor uptake of vaccines. These negative impacts
are further compounded by the highly politicised Dengvaxia controversy where individuals,
especially parents of school-age children, felt that health institutions and governments were
experimenting on them [9, 12] with our participants relating the COVID-19 vaccine ‘experiment’ with the dengue vaccine. In addition, inadequate supply, logistical challenges, and perceptions about the inefficiency and inflexibility of the system negatively impact vaccination
rates in the country. As of 16 September 2021, only 3 in 10 Filipinos received one dose with
significant differences between population groups: almost all frontline and health workers
have been vaccinated while only 2 in 5 elderly Filipinos received their first dose [21]. Those in
the third priority group have higher rates than the elderly population group, which were
offered the vaccines earlier. Apart from individual reasons, marginalised and vulnerable
groups such as the elderly have reported not being able to get their vaccine due to lack of home
vaccination services and guidance in using online registration systems. The system will need to
consider needs of all population groups to improve vaccination uptake. In all these, trust in the
health system needs to be maintained, while disregarding regulations and policies in place can
erode trust in the vaccination process.
In the Philippines, the national government has the responsibility to procure, allocate, and
distribute the vaccines to the different provinces and municipalities, but it is the local
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government that is responsible for last-mile transport and actual inoculation. This results in
wide variations in client registration and procedures between different localities. This underlines the need to identify best practices in vaccine rollout systems to implement a system that
is efficient and inclusive to ensure that access to technology and mobility will not be barriers to
vaccination.
There are a number of limitations that need to be considered when interpreting our findings. First, we were not able to have representation from the A5 priority group (indigent population). While we initially were able to get a participant from this group based on the survey
response, we later found during the interview that this individual belonged to a different vaccination priority classification. This may point to issues with online data collection where
researchers are unable to reach individuals from low-resource households. Second, there may
be social desirability bias because we were unable to ensure if the respondent had other people
with them that may have caused a change in their responses. Additionally, we did not disclose
any political affiliations and interests, but participants may have been cautious in mentioning
negative experiences related to vaccination. Participants may also have chosen more positive
responses considering our background as health researchers. However, we emphasised that
they will remain anonymous and their data treated with utmost confidentiality. Lastly, factors
influencing COVID-19 vaccination uptake is context-specific, and this paper does not aim to
represent all situations and circumstances.

Conclusion
Challenges to COVID-19 vaccination may be individual, interpersonal, and/or structural,
which interact to influence decisions. Individual perceptions play a major role in the decision
to vaccinate, and such perceptions are shaped by exposure to (mis)information amplified by
the media, the community, and the health system. In the Philippines, vaccine brand hesitancy
and misinformation are prevalent due to their rapid spread through social media and sensationalism in traditional media. Information on the effectiveness of safety of vaccines regardless
of brand needs to be communicated to the public to increase COVID-19 vaccine confidence.
At the interpersonal level, exposure to networks and health workers who are opposed to vaccines heightens public skepticism of vaccination. Structural barriers including political issues
and poor implementation further contribute to vaccine refusals. The ongoing infodemic and
anti-vaccination sentiments operating at all three levels (individual, interpersonal, structural)
require empowering individuals to evaluate health information, and therefore health literacy
becomes a critical tool to combat misinformation. Families and peers also need to be involved
in these discussions as they influence vaccine uptake. Individuals engaged in vaccine promotion activities may need to be retrained on how to engage with vocal vaccine deniers in public.
Given the involvement of traditional media, trainings on public health and science communication may be helpful in reporting vaccination-related news. Public figures need to disclose
conflicts of interests and be transparent to the public, laying out the risks and benefits of vaccines. Laws should be well-implemented and equally implemented regardless of socioeconomic class or social position to encourage trust in the health care system and in vaccination
initiatives. There is also a need to study best practices in vaccine rollout to implement systems
that are efficient and inclusive so that we can vaccinate as many people against COVID-19 as
quickly and as inclusively as possible: provide technological support particularly among older
populations and allow flexible options for receiving the vaccine such as home vaccination.
Given resource limitations, the vaccination rollout could also be improved by increasing the
role of the private sector in the rollout and administration of the vaccine. The government and
health organisations will need to connect with individuals, communities, and other
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institutions, including those who are against vaccines or hesitant towards vaccines, to co-create
effective and sustainable solutions.
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